Tham khảo Camazepam

  1. ↑ DE Patent 2142181
  2. ↑ Tammaro, A; Picceo, MT; Gemmellaro, P; Bonaccorso, O (1977). “Camazepam versus placebo. A double-blind clinical study on geriatric patients suffering from psychic complaints. Short Communication”. Arzneimittel-Forschung 27 (11): 2177–8. PMID 23793. 
  3. ↑ Lu, XL; Yang, SK (1994). “Enantiomer resolution of camazepam and its derivatives and enantioselective metabolism of camazepam by human liver microsomes.”. Journal of Chromatography A 666 (1–2): 249–57. PMID 7911374. doi:10.1016/0021-9673(94)80387-0. 
  4. ↑ De Sarro, G; Chimirri, A; Zappala, M; Guisti, P; Lipartiti, M; De Sarro, A (1996). “Azirino1, 2-d1, 4benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice”. General Pharmacology 27 (7): 1155–62. PMID 8981061. doi:10.1016/S0306-3623(96)00049-3. 
  5. ↑ De Sarro, G; Gitto, R; Rizzo, M; Zappia, M; De Sarro, A (1996). “1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice”. General Pharmacology 27 (6): 935–41. PMID 8909973. doi:10.1016/0306-3623(95)02147-7. 
  6. ↑ De Sarro, G; Chimirri, A; Mckernan, R; Quirk, K; Giusti, P; De Sarro, A (1997). “Anticonvulsant activity of azirino1,2-d1,4benzodiazepines and related 1,4-benzodiazepines in mice”. Pharmacology Biochemistry and Behavior 58 (1): 281–9. PMID 9264104. doi:10.1016/S0091-3057(96)00565-5. 
  7. ↑ Guthy, H (1975). “The medicinal treatment of anxiety in alcoholism in the withdrawal stage (author's transl)”. Munchener Medizinische Wochenschrift 117 (35): 1387–90. PMID 241014. 
  8. ↑ Tallone, G; Ghirardi, P; Bianchi, MC; Ravaccia, F; Bruni, G; Loreti, P (1980). “Reaction time to acoustic or visual stimuli after administration of camazepam and diazepam in man”. Arzneimittel-Forschung 30 (6): 1021–4. PMID 6106497. 
  9. ↑ Morino, A; Sasaki, H; Mukai, H; Sugiyama, M (1986). “Receptor-mediated model relating anticonvulsant effect to brain levels of camazepam in the presence of its active metabolites”. Journal of Pharmacokinetics and Biopharmaceutics 14 (3): 309–21. PMID 2878071. doi:10.1007/BF01106709. 
  10. ↑ Ferrillo, F; Balestra, V; Carta, F; Nuvoli, G; Pintus, C; Rosadini, G (1984). “Comparison between the central effects of camazepam and temazepam. Computerized analysis of sleep recordings”. Neuropsychobiology 11 (1): 72–6. PMID 6146112. doi:10.1159/000118055. 
  11. ↑ Shibuya, T; Field, R; Watanabe, Y; Sato, K; Salafsky, B (1984). “Structure-affinity relationships between several new benzodiazepine derivatives and 3H-diazepam receptor sites”. Japanese Journal of Pharmacology 34 (4): 435–40. PMID 6144807. doi:10.1254/jjp.34.435. 
  12. ↑ Morino, A; Nakamura, A; Nakanishi, K; Tatewaki, N; Sugiyama, M (1985). “Species differences in the disposition and metabolism of camazepam”. Xenobiotica 15 (12): 1033–43. PMID 2868575. doi:10.3109/00498258509049098. 
  13. ↑ Riva, R; Albani, F; Baruzzi, A (1982). “Quantitative determination of camazepam and its metabolite temazepam in man by gas-liquid chromatography with electron-capture detection”. Il Farmaco; edizione pratica 37 (1): 15–9. PMID 6120096. 
  14. ↑ Legheand J, Cuisinaud G, Bernard N, Riotte M, Sassard J (1982). “Pharmacokinetics of intravenous camazepam in dogs”. Arzneimittel-Forschung 32 (7): 752–6. PMID 6127087. 
  15. ↑ Nicholson, AN; Stone, BM (1982). “Hypnotic activity and effects on performance of lormetazepam and camazepam--analogues of temazepam”. British Journal of Clinical Pharmacology 13 (3): 433–9. PMC 1402107. PMID 6120717. doi:10.1111/j.1365-2125.1982.tb01398.x. 
  16. ↑ Stricker, BH (1984). “Skin disorders caused by the use of camazepam (Albego)”. Nederlands tijdschrift voor geneeskunde 128 (18): 870–2. PMID 6145108. 
  17. ↑ Schmitt, EJ; Rochels, R; Beck, D; Mauersberg, L (1980). “Visual perception under the influence of a tranquilizer (author's transl)”. Klinische Monatsblätter für Augenheilkunde 177 (6): 875–7. PMID 6110803. doi:10.1055/s-2008-1057748.